Article references (19 references )


  1. Marteil AM, Sapin R, Jean Didier N. La macroprolactine: implications biologiques et cliniques. Immuno-analyse & Biologie Spécialisée. 01 November 2000; 15(6): 396-401. Google Scholar

  2. Whittaker PG, Wilcox T, Lind T. Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin. J Clin Endocrinol Metab. 1981 Oct; 53(4): 863-6. PubMed | Google Scholar

  3. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab. 2001 Jun; 86(6): 2743-6. PubMed | Google Scholar

  4. Richa V, Rahul G, Sarika A. Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice. J Reprod Infertil. 2010 Oct-Dec; 11(3): 161–167. PubMed | Google Scholar

  5. Andersen AN, Pedersen H, Djursing H, Andersen BN, Friesen HG. Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinemia and spontaneous conception. Fertility and sterility. 1982 Nov; 38(5): 625-8. Google Scholar

  6. Hattori N. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J Clin Endocrinol Metab. 1996 Feb; 81(2): 586-90. PubMed | Google Scholar

  7. Coussieu C. Le dosage de la prolactine aujourd'hui. Immunoanal Biol Spéc. 2000; 15: 186-90. Google Scholar

  8. Gilson G, Schmit P, Thix J, Hoffman JP, Humbel RL. Prolactin results for samples containing macroprolactin are method and sample dependent. Clin Chem. 2001 Feb; 47(2): 331-3. PubMed | Google Scholar

  9. Cortet-Rudelli C, Sapin R, Bonneville JF, Brue T. Etiological diagnosis of hyperprolactinemia. Ann Endocrinol (Paris). 2007 Jun; 68(2-3): 98-105. PubMed | Google Scholar

  10. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab. 2005 Jul; 90(7): 3927-32. PubMed | Google Scholar

  11. Alfonso A, Rieniets KI, Vigersky RA. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2006 May-Jun;12(3): 275-80. Google Scholar

  12. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem. 2003 Sep; 49(9): 1504-9. PubMed | Google Scholar

  13. Donadio F, Barbieri A, Angioni R, Mantovani G, Beck-Peccoz P, Spada A et al. Patients with macroprolactinaemia: clinical and radiological features. Eur J Clin Invest. 2007 Jul; 37(7): 552-7. PubMed | Google Scholar

  14. Fahie-Wilson M, Smith TP. Determination of prolactin: The macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013 Oct; 27(5): 725-42. PubMed | Google Scholar

  15. Mounier C, Trouillas J, Claustrat B, Duthel R, Estour B. Macroprolactinaemia associated with prolactin adenoma. Hum Reprod. 2003 Apr; 18(4): 853-7. PubMed | Google Scholar

  16. Cavaco B, Leite V, Santos MA, Arranhado E, Sobrinho LG. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma. J Clin Endocrinol Metab. 1995 Aug; 80(8): 2342-6. PubMed | Google Scholar

  17. Olukoga AO. Macroprolactinemia is clinically important. J Clin Endocrinol Metab. 2002 Oct; 87(10): 4833-4; author reply 4834. PubMed | Google Scholar

  18. Sapin R, Schlienger JL. Macroprolactinémie. Immunoanalyse & Biologie Spécialisée. 2005; 419(5): 265-342. Google Scholar

  19. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab. 2002 Feb; 87(2): 581-8. PubMed | Google Scholar